Clinical Trial Update: Treating Bacterial Overgrowth in Parkinson's Disease [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 clinical trial investigated treating small intestinal bacterial overgrowth in Parkinson's disease with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Small Intestinal Bacterial Overgrowth

Snippet

Sponsor: University of Cincinnati | Conditions: Parkinson's Disease, Small Intestinal Bacterial Overgrowth | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-03-01